Lipid-Lowering Therapy in the 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia: A Perspective From China
1. 请及时下载文件确认是否正确, 系统将在 2026-06-01 15:36:24 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
JJ Li
Journal of the American College of Cardiology, 2026
jacc.org
With rapid economic growth and multifac-eted changes (environmental, social, and individual), China is facing a cardiovascular disease crisis. Notably, more than 40% of deaths are attributable to atherosclerotic cardiovascular disease (ASCVD) among urban (44.3%) and rural (46.7%) residents in China. In stark contrast to the decrease observed in high-income countries, the number of ASCVD deaths in China has nearly doubled over the past decades. 1 This burden continues to escalate, presenting a severe challenge for …
